In the News

Pediatricians Want Parents to Stop Giving Toddlers Digital Toys – Reuters

Read article – Quotes Jennifer Emond, assistant professor of biomedical data science and of pediatrics, in an article about a study that found that interactive digital toys and mobile apps designed for little kids get in the way of creative play and interactions with caregivers that are essential for child development. “Often parents may feel pressure to get their kids the newest digital educational toy for their children, but this … is not needed,” says Emond, who was not involved in the study. “Toys can be crafted from supplies available at home … We don’t need to spend a lot of money on toys to help our children develop; simpler may be better.” (Picked up by Eyewitness News.)

Before You Get Those Screening Tests, Ask These Questions – Consumer Reports

Read article – Quotes Steven Woloshin, professor of The Dartmouth Institute for Health Policy and Clinical Practice, medicine, and community and family medicine, about the questions you should ask your doctor before taking a screening test for signs of a disease before it shows symptoms. “It only makes sense to get screened if you’re testing for something you can do something about—and if treatment is more effective when the problem is detected before symptoms develop,” says Woloshin.

Americans Are Dying Even Younger – Route Fifty

Read article – Quotes Ellen Meara, professor of The Dartmouth Institute for Health Policy and Clinical Practice and adjunct professor in economics, in an article about three recent reports released by the Centers for Disease Control and Prevention last week that found that American life expectancy is continuing its recent decline. “Sadly, this result confirms what many suspected based on data coming out earlier this year: that we continue to lose ground due in large part to preventable causes of death like overdose, suicide, and for deaths due to chronic lower respiratory diseases, many of which are attributable to tobacco use,” says Meara.

Americans Are Dying Even Younger – The Atlantic

Read article – Quotes Ellen Meara, professor of The Dartmouth Institute for Health Policy and Clinical Practice and adjunct professor in economics, in an article about how drug overdoses and suicides are causing American life expectancy to drop. “Sadly, this result confirms what many suspected based on data coming out earlier this year, that we continue to lose ground due in large part to preventable causes of death like overdose, suicide, and from deaths due to chronic lower respiratory diseases, many of which are attributable to tobacco use,” says Meara.

A Life: Barbara Treasure Blough, 1924-2018; ‘So Smart, So Effective, So Efficient and So Caring’ – Valley News

Read article – An article remembering the life of Barbara Blough, MALS ’74, who provided more than 50 years of enthusiastic public service to the Upper Valley community. The article mentions that Blough was the founding director of alumni affairs at the Geisel School of Medicine (known as Dartmouth Medical School at the time), where she raised funds for the school, created the alumni magazine, and started the school’s first alumni program — all of which required passionate, persuasive outreach. The medical school recognized her 15 years of service with a conference room in her name.

Fish Oil Drug Looks Heart-Healthy. Just Don’t Swallow It Hook, Line and Sinker. – Kaiser Health News

Read article – Cites comments by Steven Woloshin, professor of The Dartmouth Institute for Health Policy and Clinical Practice, medicine, and community and family medicine, in an article about biopharma company Amarin’s claims that its clinical trial results for the Vascepa show that it could transform heart disease prevention. Woloshin noted that the trial focused on patients who had high triglyceride levels, a history of heart disease or another elevated risk, and were already taking statins, meaning that the benefits of the drug are focused on a specific population.

Fish Oil Drug Vascepa Looks Heart Healthy—But Is It Really? – The Daily Beast

Read article – Cites comments by Steven Woloshin, professor of The Dartmouth Institute for Health Policy and Clinical Practice, medicine, and community and family medicine, in an article about biopharma company Amarin’s claims that its clinical trial results for the Vascepa show that it could transform heart disease prevention. Woloshin noted that the trial focused on patients who had high triglyceride levels, a history of heart disease or another elevated risk, and were already taking statins, meaning that the benefits of the drug are focused on a specific population.

FDA Tobacco Crackdown Draws Fire From Right – The Hill

Read article – Quotes Samir Soneji, associate professor of The Dartmouth Institute for Health Policy and Clinical Practice, in an article about the Food and Drug Administration’s (FDA) recently proposed sweeping new restrictions on the sale of e-cigarettes in an effort to cut down on teenage vaping. The agency also said it would seek to ban menthol-flavored traditional cigarettes and flavored cigars. “If the vaping industry is serious, there’s no reason for Juul to sell watermelon, mint or fruit medley … because it attracts kids and we’re starting to learn it doesn’t appeal to adult smokers,” says Soneji.